This is a preview of subscription content, log in via an institution to check access.
Notes
2012 US dollars
Reference
Bamrungsawad N, et al. Cost-Utility Analysis of Intravenous Immunoglobulin for the Treatment of Steroid-Refractory Dermatomyositis in Thailand. PharmacoEconomics : 14 Mar 2015. Available from: URL: http://doi.org/10.1007/s40273-015-0269-8
Rights and permissions
About this article
Cite this article
IVIG cost effective for steroid-refractory dermatomyositis. PharmacoEcon Outcomes News 724, 15 (2015). https://doi.org/10.1007/s40274-015-1993-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-1993-1